Rigel Pharmaceuticals, Inc. (RIGL)

Last Closing Price: 40.09 (2026-11-20)

Beginning Cash (Quarterly)

Beginning Cash: The amount of cash reported by the company on its previous statement.

Rigel Pharmaceuticals, Inc. (RIGL) had Beginning Cash of $40.64M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$80.89M
$13.19M
$10.78M
$70.11M
$63.78M
$17.11M
$0.30M
$17.41M
$17.41M
$13.19M
$13.19M
$13.19M
$13.19M
$17.11M
$18.86M
18.71M
20.44M
$0.70
$0.65
Balance Sheet Financials
$188.52M
--
$335.35M
$523.88M
$78.77M
--
--
$78.77M
$445.11M
$350.52M
$445.11M
18.83M
Cash Flow Statement Financials
$67.94M
$-8.97M
$-52.91M
Beginning Cash
$40.64M
$46.70M
$6.07M
$15.15M
--
--
Fundamental Metrics & Ratios
2.39
--
--
--
0.02
86.67%
21.15%
21.15%
--
21.52%
16.30%
$67.94M
--
--
--
0.15
0.68
1.43
62.82
2.96%
3.76%
2.52%
2.96%
$23.64
$3.32
$3.32